GHK-Cu stimulates collagen production by up to 70% in some research models while simultaneously activating enzymes that break down damaged collagen
Now available in a daily serum at 3% concentration 30x the industry standard
In recent years, small molecule antagonists, antisense oligonucleotides, and monoclonal antibodies targeting GCGR have been developed and demonstrated efficacy in improving glycemic control in both rodent models of diabetes and human patients with diabetes 8,9,10,11,12,13
This deep dive covers what 5+ years of GLP-1, growth hormone, and research peptide data actually shows from cardiovascular outcomes and cancer risk to muscle loss, bone health, and what clinical oversight looks like in practice
Treatment frequency varies depending on your health profile and wellness goals